Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control https://t.co/dIGe1ZQ3jF — Marisa Peer (@PeerMarisa) October 2, 2018
Disruption in combination inhaled corticosteroid therapy may impact patients' symptoms and disease control https://t.co/dIGe1ZQ3jF
No comments:
Post a Comment